查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1987207

正压通气（气道正压）呼吸器市场规模、份额、趋势和预测：按产品类型、最终用户和地区划分，2026-2034年

Positive Airway Pressure Devices Market Size, Share, Trends and Forecast by Product Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2025年全球正压通气（PAP）呼吸器市场规模为40亿美元。展望未来，IMARC集团预测，该市场将在2026年至2034年间以4.93%的复合年增长率成长，到2034年达到62亿美元。目前，北美市场主导地位，预计2025年将占35%的市场。该地区受益于许多因素，例如先进的医疗基础设施、完善的正压呼吸装置保险报销体系、较高的临床认知度以及患者对PAP治疗的强劲需求，所有这些因素都促进了PAP市场份额的成长。

推动这一市场发展的因素包括流行病学、技术和政策等多方面因素。阻塞型睡眠呼吸中止症（OSA）在全球范围内的盛行率不断上升，这主要归因于肥胖症的增加、久坐的生活方式以及人口老龄化，从而扩大了持续气道正压通气（PAP）治疗的患者群体。此外，人们越来越意识到未经治疗的睡眠呼吸中止症会导致高血压、糖尿病和忧郁症严重的健康后果，这促使人们寻求早期治疗。政府优惠的报销政策降低了经济门槛，促进了有效设备的普及。此外，新兴经济体医疗保健支出的成长也逐渐扩大了PAP设备的覆盖范围，从而扩大了全球患者群体，并推动了PAP设备市场的成长。

美国之所以成为持续性正压呼吸器（PAP）设备市场的领先地区，原因有很多。美国拥有完善的医疗保健体系，PAP治疗的保险覆盖范围广，睡眠诊断设施先进，且医疗专业人员对睡眠障碍的认知度很高。此外，医疗设备研发的大量投入也促使新一代PAP设备迅速推向市场。推动正压呼吸装置广泛应用的重要因素之一是肥胖相关睡眠呼吸中止症病例的不断增加。一项发表于2025年《瑞思迈》（ResMed）杂誌的研究估计，届时美国将有约7,700万成年人患有此病，较2020年增长约35%，30至69岁成年人中约有46%受到影响。此外，远端医疗与PAP设备的结合，也有助于更好地监测治疗过程，并提高患者对治疗方案的依从性。

正压通气（PAP）设备市场趋势：

人们越来越意识到睡眠呼吸中止症的严重后果

阻塞型睡眠呼吸中止症（OSA）在全球日益普遍，是推动PAP治疗需求成长的最重要因素之一。 OSA的特征是睡眠期间反覆出现呼吸暂停，与肥胖、老龄化以及久坐不动的生活方式和饮酒等因素密切相关。随着越来越多的医疗专业人员和公共卫生组织投入大规模筛检计画和宣传宣传活动，越来越多的人被诊断出患有OSA，因此，接受PAP治疗的患者也越来越多。世界各国政府都将睡眠健康列为优先事项，保险公司也正在扩大承保范围，将PAP治疗及相关设备纳入其中。随着人们越来越认识到未确诊和未治疗的OSA与高血压、中风、心臟衰竭和2型糖尿病等慢性疾病之间的关联，对OSA的诊断和治疗需求也变得更加迫切。 2025 年，SleepRes 公司宣布其「Kricket PAP 系统」已获得 FDA 510(k) 批准，该系统采用 Kairos 正压通气 (KPAP) 疗法治疗体重 66 磅（约 30 公斤）或以上的阻塞型睡眠呼吸中止症症 (OSA) 患者。

对家用PAP治疗的需求日益增长

居家医疗管理模式转移正在从根本上革新正压通气（PAP）治疗市场及其终端使用者。不断上涨的医疗成本、医院感染风险以及对以患者为中心的护理日益增长的需求，都促使越来越多的患者选择在家中舒适地进行睡眠呼吸中止症的自我管理治疗。现代家用PAP设备便携易用，配备低噪音马达和直觉的介面，专为患者独立使用而设计。居家睡眠监测服务的日益普及也简化了治疗流程，使患者能够在睡眠检查室之外快速开始PAP治疗。医疗保健专业人员越来越多地利用PAP设备上的远距远端医疗平台来追踪治疗依从性并远端调节压力，从而最大限度地减少后续復诊的需求。 2025年，Happy Health的「Happy Ring」获得了FDA核准用于家庭睡眠监测。即使与多导睡眠图这一黄金标准相比，它也拥有极高的准确性，这表明在这个快速变化的行业中，诊断技术与居家照护正在迅速融合。

提昇设备性能的技术进步

PAP（持续性呼吸道正压通气）技术的创新正在改变睡眠呼吸障碍的治疗方式。持续性气道正压通气（PAP）设备市场前景广阔，这主要得益于市场对更安静、更便携且具备先进功能的设备的需求，例如自动压力调节、加热加湿器以及基于云端的监测系统，这些系统使医护人员能够远端追踪患者的治疗依从性。这些功能已被证实有助于提高患者的治疗依从性，而这对于有效管理阻塞性睡眠呼吸中止症（OSA）至关重要。具备蓝牙连接和行动应用程式功能的智慧型PAP设备的开发，使患者能够追踪治疗资讯并获得即时回馈，这也促进了治疗的个人化。此外，利用人工智慧（AI）演算法根据患者的呼吸模式即时调节压力水平的应用也日益普及。 2026年，专注于居家照护尖端产品的领先医疗技术公司Inogen, Inc.宣布推出Aurora CPAP面罩，为其不断扩展的产品线再添新成员。 Aurora 的推出标誌着 Inogen 在加强其呼吸护理产品组合、为阻塞型睡眠呼吸中止症(OSA) 患者提供高品质、有效的面罩的策略上迈出了重要一步。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章：引言

第五章：全球正压通气（气道正压通气）呼吸器市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品类型划分

  • 自动正压通气（APAP）装置
  • 持续性阳压呼吸器（CPAP）装置
  • 双级正压通气（BiPAP）装置

第七章 市场区隔：依最终用户划分

  • 医院和睡眠测试机构
  • 居家照护
  • 其他的

第八章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章 SWOT 分析

第十章：价值链分析

第十一章：波特五力分析

第十二章：价格分析

第十三章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • 3B Medical Inc.
    • Apex Medical Corp.
    • Compumedics Limited（D & DJ Burton Holdings Pty Ltd.）
    • Drive Devilbiss Healthcare（Drive International LLC）
    • Fisher & Paykel Healthcare Limited
    • Koninklijke Philips NV
    • Resmed Inc.
    • Smiths Group Plc
    • Somnetics International Inc.
    • Vyaire Medical Inc.
Product Code: SR112026A3679

The global positive airway pressure devices market size was valued at USD 4.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.2 Billion by 2034, exhibiting a CAGR of 4.93% from 2026-2034. North America currently dominates the market, holding a market share of 35% in 2025. The region benefits from advanced healthcare infrastructure, well-established reimbursement policies for sleep disorder treatments, high clinical awareness, and strong patient demand for PAP therapy, all collectively contributing to the positive airway pressure devices market share.

The market is driven by a combination of epidemiological, technological, and policy related factors. The increasing global occurrence of obstructive sleep apnea (OSA) driven by the heightened incidence of obesity, sedentary lifestyle habits, and aging populations, is creating a large pool of patient base for positive airway pressure (PAP) therapy. Apart from this, the increasing awareness about the severe health consequences of untreated sleep apnea, like hypertension, diabetes, and depression, is encouraging people to seek timely treatment. Favorable reimbursement policies by the government are lowering economic barriers and facilitating the adoption of effective devices. In addition, the increasing healthcare expenditure in emerging countries is gradually rising access to PAP devices, thereby expanding the global patient base and supporting the positive airway pressure devices market growth.

The United States has become a prominent area in the positive airway pressure devices market because of numerous reasons. The country has an established healthcare system with extensive insurance coverage for PAP therapy, advanced sleep diagnostic facilities, and a high level of awareness among healthcare professionals about sleep disorders. The United States also has strong investments in medical device R&D, which has led to the quick introduction of next-generation PAP devices in the market. One of the most important factors that have contributed to the adoption of positive airway pressure devices is the rising number of obesity-related sleep apnea cases, as stated in a study published in Resmed in 2025, nearly 77 million U.S. adults, which shows a relative increase of almost 35% since 2020 and affects 46% of adults aged 30-69 years. The integration of telehealth with PAP devices has also helped in monitoring therapy sessions and improving patient compliance with treatment regimens in the United States.

POSITIVE AIRWAY PRESSURE DEVICES MARKET TRENDS:

Heightened Awareness about Consequences of Sleep Apnea

The growing international incidence of obstructive sleep apnea represents one of the most influential drivers of demand for PAP therapy. OSA, which is defined by recurrent episodes of breathing cessation during sleep, has been closely linked to obesity, advancing age, and lifestyle factors such as a sedentary lifestyle and alcohol use. As greater numbers of healthcare providers and public health agencies invest in large-scale screening programs and education campaigns, more patients are being diagnosed with OSA and subsequently treated with PAP therapy. Governments in various international regions have placed a high priority on sleep health initiatives, with insurance companies expanding their coverage to include PAP therapy and accessories. The growing recognition of the link between undiagnosed and untreated OSA and chronic diseases such as hypertension, stroke, heart failure, and type 2 diabetes is further fueling the need for diagnosis and treatment. In 2025, SleepRes, Inc. announced that it has received FDA 510(k) clearance for its Kricket PAP system, which employs Kairos Positive Airway Pressure (KPAP) to treat obstructive sleep apnea in patients weighing more than 66 pounds.

Escalating Demand for Home-Based PAP Therapy

The paradigm shift towards home-based healthcare management is, at its core, revolutionizing the positive airway pressure devices market trends and end-users of positive airway pressure devices. Increasing healthcare expenditures, the risk of hospital-acquired infections, and the growing demand for patient-centric care have collectively encouraged more patients to take charge of their sleep apnea treatment in the comfort of their own homes. Contemporary home-use PAP devices are extremely portable, easy to use, and engineered with noise-reduced motors and intuitive interfaces that allow for independent use. The growing availability of home sleep testing services has also made the process more streamlined, allowing patients to quickly begin PAP therapy outside of the sleep lab. Healthcare professionals are increasingly using telemedicine platforms available on PAP devices to track therapy compliance and adjust pressures remotely, minimizing the need for follow-up consultations. In 2025, Happy Health's Happy Ring received FDA approval for home sleep testing, boasting high accuracy rates compared to the gold standard of polysomnography, illustrating the rapidly increasing integration of diagnostic technology and home-based care in this rapidly changing industry.

Technological Advancements Enhancing Device Performance

Innovation in PAP technology is changing the face of treatment for sleep-disordered breathing. The positive airway pressure devices market outlook is being influenced by the need for quieter, more portable devices with advanced features such as automatic pressure adjustment, heated humidifiers, and cloud-based monitoring systems that allow remote tracking of patient compliance by healthcare professionals. These features have been demonstrated to improve patient compliance, which has been a major factor in the effective management of OSA. The development of smart PAP devices with Bluetooth connectivity and mobile apps that enable patients to track therapy information and receive real-time feedback is also personalizing treatment. The use of artificial intelligence algorithms to adjust pressure levels in real-time according to the patient's breathing patterns is also becoming popular in the industry. In 2026, Inogen, Inc., a prominent medical technology firm focused on cutting-edge respiratory products for home care, revealed the introduction of Aurora CPAP masks, a new item in the growing Inogen lineup. Aurora's launch represents an important step in Inogen's strategy to enhance its respiratory care offerings and provide patients with quality, effective masks for obstructive sleep apnea (OSA).

POSITIVE AIRWAY PRESSURE DEVICES INDUSTRY SEGMENTATION:

Analysis by Product Type:

  • Automatic Positive Airway Pressure (APAP) Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bi-level Positive Airway Pressure (BiPAP) Devices

Continuous positive airway pressure (CPAP) Devices holds 60% of the market share. CPAP devices are the most widely prescribed treatment for obstructive sleep apnea, delivering a continuous, steady stream of pressurized air through a mask to maintain airway patency during sleep. Their clinical effectiveness, cost-efficiency relative to advanced PAP systems, and simplicity of use have firmly established them as the gold standard for OSA management among healthcare providers and patients alike. Ongoing innovation in CPAP technology has further strengthened this dominance, with newer models featuring quieter motors, ergonomic mask designs, auto-adjusting pressure capabilities, and integrated digital health tools that enable remote patient monitoring and compliance tracking. The widespread availability of CPAP devices through home medical equipment providers and online channels has substantially improved accessibility across diverse markets. Strong reimbursement coverage for CPAP devices by government insurance programs in North America and Europe continues to support adoption.

Analysis by End User:

  • Hospitals and Sleep Labs
  • Home Care
  • Others

Hospitals and sleep labs lead the market with a share of 48%. These specialized clinical settings provide comprehensive diagnostic and therapeutic services for patients with sleep-disordered breathing, deploying advanced PAP devices as part of structured treatment protocols under medical supervision. Hospitals are equipped with state-of-the-art sleep laboratories capable of conducting full polysomnography studies, which enable clinicians to accurately titrate PAP pressure settings for individual patients. The presence of multidisciplinary care teams, including pulmonologists, neurologists, and respiratory therapists, ensures high-quality OSA management in hospital environments. Institutional procurement of PAP devices is supported by favorable reimbursement frameworks in key markets, particularly in North America and Europe. Additionally, the integration of hospital-based PAP programs with broader chronic disease management platforms for conditions such as cardiovascular disease and metabolic disorders supports coordinated patient care.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America, accounting for 35% of the share, enjoys the leading position in the market. The region's market leadership is underpinned by high sleep apnea prevalence, advanced healthcare infrastructure, and robust clinical adoption of PAP therapy. The United States has a well-established sleep medicine ecosystem featuring a large network of accredited sleep centers, experienced specialists, and strong insurance reimbursement policies that facilitate patient access to PAP devices. Canada also demonstrates consistent PAP device adoption, driven by government-funded healthcare services and increasing public awareness of sleep disorder management. Moreover, the region benefits from the concentration of leading PAP device manufacturers and an active regulatory environment that facilitates rapid approval and commercialization of innovative products. According to a study published in Respiratory Medicine in September 2025, an estimated 83.7 million adults, representing 32.4% of the United States adult population, had obstructive sleep apnea as of 2024, directly reflecting the robust and growing clinical demand for positive airway pressure devices market forecast-aligned therapeutic interventions across the region.

KEY REGIONAL TAKEAWAYS:

United States Positive Airway Pressure Devices Market Analysis

The United States positive airway pressure devices market is driven by its highly developed healthcare infrastructure, robust sleep medicine specialty ecosystem, and among the highest per-capita rates of sleep apnea diagnosis globally. The widespread availability of accredited sleep diagnostic centers, combined with comprehensive Medicare and private insurance coverage for PAP devices and accessories, significantly reduces the financial burden on patients and encourages timely treatment initiation. Increasing public health campaigns by professional organizations such as the American Academy of Sleep Medicine have substantially elevated awareness of OSA and its associated risks, including cardiovascular disease, stroke, and metabolic disorders. The integration of digital health technologies with PAP devices, including smartphone applications, cloud-based compliance monitoring, and remote patient management platforms, is further improving therapy adherence rates across the US population. Ongoing investment in R&D by domestic manufacturers ensures a steady pipeline of innovative PAP products entering the market. In February, Zydus Lifesciences revealed the introduction of PEPAIR, an Oscillating Positive Expiratory Pressure (OPEP) device aimed at aiding mucus clearance and enhancing breathing in individuals with chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis.

Europe Positive Airway Pressure Devices Market Analysis

The European positive airway pressure devices market demonstrates consistent growth, supported by universal healthcare systems in major economies including Germany, France, the United Kingdom, Italy, and Spain that provide broad reimbursement coverage for sleep disorder diagnosis and PAP therapy. High awareness levels among healthcare professionals and expanding patient education initiatives have supported increased OSA diagnosis rates across the region. European regulatory bodies maintain rigorous standards for PAP device safety and efficacy, ensuring the availability of high-quality products across regional markets. The aging population in Western Europe, combined with rising obesity rates in younger demographics, continues to expand the pool of at-risk patients requiring PAP therapy. Strong investment in sleep medicine research and clinical trials across European academic institutions is generating evidence that supports guideline-driven PAP prescribing practices. In July 2024, the French government granted reimbursement approval for an innovative neurostimulation-based OSA therapy, reflecting Europe's strong policy commitment to expanding treatment options for sleep disorder patients and underscoring the region's progressive healthcare policy environment.

Asia-Pacific Positive Airway Pressure Devices Market Analysis

The Asia-Pacific positive airway pressure devices market is expanding rapidly, driven by increasing OSA diagnosis rates, growing healthcare expenditure, and improving medical infrastructure across major economies including China, Japan, India, South Korea, and Australia. Rising obesity rates and demographic aging across the region are significantly elevating the burden of sleep-disordered breathing, stimulating demand for PAP therapy. In Japan and South Korea, advanced healthcare infrastructure and strong insurance coverage are supporting high device adoption rates. In China and India, awareness campaigns and the expansion of sleep diagnostic centers are progressively closing the gap between OSA prevalence and diagnosis. As per a report by the Australian Institute of Health and Welfare published in November 2024, the Australian government invested USD 178.7 billion toward healthcare infrastructure development, significantly improving access to diagnostic and therapeutic services, including PAP devices, across the region.

Latin America Positive Airway Pressure Devices Market Analysis

The Latin America positive airway pressure devices market is at an emerging stage but exhibits significant growth potential, driven by increasing awareness of sleep apnea, expanding private healthcare networks, and a rising burden of obesity across the region. Countries including Brazil and Mexico are primary contributors to market activity, supported by improving access to sleep diagnostic services and government-led chronic disease management programs. According to the Pan American Health Organization (PAHO), obesity prevalence among adults in Latin America has increased substantially, with a major section of the adult population classified as obese across several major economies in 2024, directly elevating sleep apnea prevalence and fueling demand for PAP devices.

Middle East and Africa Positive Airway Pressure Devices Market Analysis

The Middle East and Africa positive airway pressure devices market is gradually developing, with significant growth potential concentrated in Gulf Cooperation Council (GCC) states including Saudi Arabia and the United Arab Emirates, where high obesity prevalence and rising healthcare investment are supporting market expansion. Africa's market remains nascent, constrained by limited healthcare infrastructure and low awareness. According to the World Health Organization (WHO), some GCC nations reported adult obesity rates increasing excessively, directly elevating the epidemiological burden of obstructive sleep apnea and increasing demand for PAP therapy. Government-backed healthcare modernization programs across the region are progressively expanding access to sleep diagnostic services and PAP treatment options.

COMPETITIVE LANDSCAPE:

The global positive airway pressure devices market is characterized by intense competition, with established multinational corporations and specialized medical device companies competing through continuous product innovation, regulatory approvals, and strategic collaborations. Leading players are focused on expanding their PAP device portfolios with advanced features including automated pressure adjustment, reduced noise levels, smart connectivity, and integrated cloud-based data platforms to differentiate their offerings and improve patient adherence. Strategic investments in research and development remain a priority as companies seek to address common barriers to long-term therapy compliance, including device discomfort and complexity. Partnerships with telehealth providers, insurance companies, and hospital networks are being pursued to enhance market reach and streamline patient access. While regulatory compliance and post-market surveillance requirements present ongoing operational complexities, leading manufacturers are investing in quality management systems and clinical evidence generation to support commercialization efforts across international markets and sustain their competitive positions.

The report provides a comprehensive analysis of the competitive landscape in the positive airway pressure devices market with detailed profiles of all major companies, including:

  • 3B Medical Inc.
  • Apex Medical Corp.
  • Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
  • Drive Devilbiss Healthcare (Drive International LLC)
  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips N.V.
  • Resmed Inc.
  • Smiths Group Plc
  • Somnetics International Inc.
  • Vyaire Medical Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the positive airway pressure devices market?

2. What is the future outlook of the positive airway pressure devices market?

3. What are the key factors driving the positive airway pressure devices market?

4. Which region accounts for the largest positive airway pressure devices market share?

5. Which are the leading companies in the global positive airway pressure devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Positive Airway Pressure Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Automatic Positive Airway Pressure (APAP) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Continuous Positive Airway Pressure (CPAP) Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bi-level Positive Airway Pressure (BiPAP) Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Sleep Labs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Home Care
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3B Medical Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Apex Medical Corp.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Drive Devilbiss Healthcare (Drive International LLC)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Fisher & Paykel Healthcare Limited
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Koninklijke Philips N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Resmed Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Smiths Group Plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Somnetics International Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Vyaire Medical Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Positive Airway Pressure Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Positive Airway Pressure Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Positive Airway Pressure Devices Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Positive Airway Pressure Devices Market: Breakup by End User (in %), 2025
  • Figure 5: Global: Positive Airway Pressure Devices Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Positive Airway Pressure Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Positive Airway Pressure Devices (Automatic Positive Airway Pressure (APAP) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Positive Airway Pressure Devices (Automatic Positive Airway Pressure (APAP) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Positive Airway Pressure Devices (Continuous Positive Airway Pressure (CPAP) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Positive Airway Pressure Devices (Continuous Positive Airway Pressure (CPAP) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Positive Airway Pressure Devices (Bi-level Positive Airway Pressure (BiPAP) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Positive Airway Pressure Devices (Bi-level Positive Airway Pressure (BiPAP) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Positive Airway Pressure Devices (Hospitals and Sleep Labs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Positive Airway Pressure Devices (Hospitals and Sleep Labs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Positive Airway Pressure Devices (Home Care) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Positive Airway Pressure Devices (Home Care) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Positive Airway Pressure Devices (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Positive Airway Pressure Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: North America: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: North America: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: United States: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: United States: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Canada: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Canada: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Asia Pacific: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Asia Pacific: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: China: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: China: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Japan: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Japan: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: India: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: India: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: South Korea: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: South Korea: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Australia: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Australia: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Indonesia: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Indonesia: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Others: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Others: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Europe: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Europe: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Germany: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Germany: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: France: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: France: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: United Kingdom: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: United Kingdom: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Italy: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Italy: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Spain: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Spain: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Russia: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Russia: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Latin America: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Latin America: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Brazil: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Brazil: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Mexico: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Mexico: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Middle East and Africa: Positive Airway Pressure Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Middle East and Africa: Positive Airway Pressure Devices Market: Breakup by Country (in %), 2025
  • Figure 67: Middle East and Africa: Positive Airway Pressure Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Global: Positive Airway Pressure Devices Industry: SWOT Analysis
  • Figure 69: Global: Positive Airway Pressure Devices Industry: Value Chain Analysis
  • Figure 70: Global: Positive Airway Pressure Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Positive Airway Pressure Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Positive Airway Pressure Devices Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Positive Airway Pressure Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 4: Global: Positive Airway Pressure Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Positive Airway Pressure Devices Market: Competitive Structure
  • Table 6: Global: Positive Airway Pressure Devices Market: Key Players